BioCentury
ARTICLE | Company News

Sun Pharmaceutical, Almirall deal

August 8, 2016 7:00 AM UTC

Sun Pharma granted Almirall rights to develop and commercialize tildrakizumab for psoriasis in Europe. Sun has exclusive, worldwide rights to the compound under a 2014 deal with Merck & Co. Inc. (NYS...